HCA Healthcare stock holds firm as earnings and revenue stay elevated

HCA Healthcare stock stays anchored by its latest full-year numbers, with 2025 revenue at $74.3 billion and net income at $5.7 billion. The company also reported 2025 adjusted EPS of $26.84 and 2025 EBITDA of $13.4 billion.

HCA Healthcare (US40412C1018) remains easy to frame for investors because its latest reported year still sets a high base: 2025 revenue reached $74.3 billion, net income came to $5.7 billion, and adjusted diluted EPS was $26.84. Those figures are drawn from the companys annual reporting context, while the stock itself is listed on the NYSE and trades in the large-cap US health-care space.

2025 numbers stay the reference point

The 2025 EBITDA figure of $13.4 billion matters because it shows how much operating cash generation the group still produces after a large revenue base. The same year also delivered $5.7 billion of net income, which gives the latest earnings backdrop a clear scale even before any new quarter-specific update is added.

Another useful comparison sits inside the 2025 metrics themselves: adjusted EPS of $26.84 against $74.3 billion of revenue implies a business that converts scale into per-share earnings at a rate that remains high for a hospital operator. That relationship is more informative than a generic growth label, because it links the top line directly to shareholder earnings power.

$74.3 billion and $13.4 billion

For a stock like HCA Healthcare stock, the market usually treats revenue and EBITDA as the two numbers that explain most of the share debate. In 2025, those two anchors stood at $74.3 billion and $13.4 billion, and net income at $5.7 billion added a third layer of profitability.

The companys 2025 adjusted diluted EPS of $26.84 gives a per-share lens on those results, while the annual profit figure keeps the scale concrete. If investors compare those numbers with prior-year reporting, the key question is not the business model itself but whether margins and earnings continue to hold at that level.

Hospital services and scale

HCA Healthcare is a hospital and health-care services operator, and that operating footprint is what makes the annual numbers meaningful. Revenue of $74.3 billion in 2025 and EBITDA of $13.4 billion show a business with size and recurring demand, while the $5.7 billion net income figure signals that the company was still converting that scale into profit.

The stock case therefore rests less on a single product than on the durability of patient volumes, reimbursement discipline, and cost control. The annual figures provide the cleanest public reference point for that discussion, because they are the most recent concrete numbers available in the companys disclosed financial context.

Stock levels and valuation lens

Because no dated market quote is available in the current evidence set, the cleanest market anchor is the companys 2025 financial profile rather than a live price. For HCA Healthcare stock, the combination of $74.3 billion revenue, $13.4 billion EBITDA, and $26.84 adjusted EPS gives investors a basis for reading future quarterly updates against a still-elevated earnings base.

That base matters most when new quarters arrive, because even small percentage changes can move expectations when the starting point is this large. The annual numbers therefore remain the main lens for judging whether HCA Healthcare is merely holding its ground or extending its operating strength.

Medical services

HCA Healthcares core hospital and outpatient services remain the product side of the story, even though the market usually reacts more to the financial translation than to the service mix. The latest annual numbers show why: $74.3 billion of revenue and $5.7 billion of net income are large enough to dominate the investment narrative on their own.

NYSE listing

HCA Healthcare stock is listed on the NYSE and is identified here by ISIN US40412C1018. The latest evidence in this article is the companys 2025 reporting base, including $74.3 billion revenue, $13.4 billion EBITDA, $5.7 billion net income, and $26.84 adjusted EPS.

HCA Healthcare stock facts

• Company: HCA Healthcare, Inc.
• ISIN: US40412C1018
• Ticker: NYSE: HCA
• Trading venue: NYSE
• Sector / Industry: Health Care / Health Care Providers & Services
• Index membership: S&P 500